← Leaderboards
Vedad Delic
Va New Jersey Health Care System
$0
Attributed
$0
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2020–25$1$1$1$0$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
VA$0 · 1
By mechanism
IK2$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Va New Jersey Health Care System
Same institution · by research overlap
Others in their field
Other Emerging Leaders on “Early Onset”
- Alan D. Palkowitz · Indiana University Indianapolis$20,460,525
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- Rene S. Kahn · Icahn School Of Medicine At Mount Sinai$16,767,001
- Michal Engelman · University Of Wisconsin-Madison$11,072,310
- Colin Masters · University Of Melbourne$10,651,748
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$10,496,936
Research focus
Early OnsetEffectivenessAffectDizzinessAnimalsDopaminergic NeuronAlpha SynucleinAreaAnimal Disease ModelsBehavioralBiologicalBrainBrain InjuriesBrain RegionAppearanceClinicClinical TrialsCombatAutophagocytosisDeteriorationDiagnosisDisease ModelDisease ProgressionEnvironmental Enrichment For Laboratory Animals
Grant awards (6)
Exercise and pharmacological LRRK2 inhibition for preventing PD$0
IK2 · FY2025 · VA · contact PI
Exercise and pharmacological LRRK2 inhibition for preventing PD$0
IK2 · FY2024 · VA · contact PI
Exercise and pharmacological LRRK2 inhibition for preventing PD$0
IK2 · FY2023 · VA · contact PI
Exercise and pharmacological LRRK2 inhibition for preventing PD$0
IK2 · FY2022 · VA · contact PI
Exercise and pharmacological LRRK2 inhibition for preventing PD$0
IK2 · FY2021 · VA · contact PI
Exercise and pharmacological LRRK2 inhibition for preventing PD$0
IK2 · FY2020 · VA · contact PI